Report Tools

Idenix Pharmaceuticals, Inc. - SWOT, Strategy and Corporate Finance Report

Published: December 2012 · Publisher: MarketLine
Idenix Pharmaceuticals, Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc.
Report Type Company Profiles
Language English
Format Electronic (PDF)
Pages41
Frequency Updated Annually
Availability Will be emailed within 1 business day
Reference No. 0109-0232
Price € 129,00
Options
  • Description
  • Table of Contents
  • Ask a Question
Idenix Pharmaceuticals, Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360° view of the company.

Features:

- Detailed information on Idenix Pharmaceuticals, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Idenix Pharmaceuticals, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Idenix Pharmaceuticals, Inc. including a breakdown and examination of key business segments
- Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for Idenix Pharmaceuticals, Inc.
- Intelligence on Idenix Pharmaceuticals, Inc.nv’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Idenix Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Highlights:

Idenix Pharmaceuticals (Idenix) is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases. The company mainly focuses on the development of drugs for the treatment of viral hepatitis and HIV/AIDS. Idenix is headquartered in Cambridge, Massachusetts and employed 109 people as of December 31, 2010. The company recorded revenues of $10.2 million during the financial year ended December 2010 (FY2010), a decrease of 19% compared with FY2009. The operating loss of the company was $67.7 million during FY2010, as compared to operating loss of $54.4 million in FY2009. The net loss was $61.6 million in FY2010, as compared to net loss of $53.2 million in FY2009.

Reasons to Purchase:

- Gain understanding of Idenix Pharmaceuticals, Inc. and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess Idenix Pharmaceuticals, Inc. as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers' businesses better
- Stay up to date on Idenix Pharmaceuticals, Inc.’s business structure, strategy and prospects

Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.
Company Snapshot
Idenix Pharmaceuticals, Inc.: Company Overview
Idenix Pharmaceuticals, Inc.: Overview and Key Facts
Idenix Pharmaceuticals, Inc.: Overview
Idenix Pharmaceuticals, Inc.: Key Facts
Idenix Pharmaceuticals, Inc.: Key Employees
Idenix Pharmaceuticals, Inc.: Key Employee Biographies
Idenix Pharmaceuticals, Inc.: Major Products and Services
Idenix Pharmaceuticals, Inc.: Company History
Idenix Pharmaceuticals, Inc.: Management Statement
Idenix Pharmaceuticals, Inc.: Locations and Subsidiaries
Idenix Pharmaceuticals, Inc.: Key Competitors
Idenix Pharmaceuticals, Inc.: Company Analysis
Idenix Pharmaceuticals, Inc.: Business Description
Idenix Pharmaceuticals, Inc.: SWOT Analysis
Idenix Pharmaceuticals, Inc.: SWOT Overview
Idenix Pharmaceuticals, Inc.: Strengths
Idenix Pharmaceuticals, Inc.: Weaknesses
Idenix Pharmaceuticals, Inc.: Opportunities
Idenix Pharmaceuticals, Inc.: Threats
Idenix Pharmaceuticals, Inc.: Corporate Financial Deals Activity
Idenix Pharmaceuticals, Inc.: Financial Deals Overview
Idenix Pharmaceuticals, Inc.: Targets and Partners
Idenix Pharmaceuticals, Inc.: Top Deals 2009 - 2013YTD*
Idenix Pharmaceuticals, Inc.: Advisors
Idenix Pharmaceuticals, Inc.: Top Legal Advisors
Idenix Pharmaceuticals, Inc.: Top Financial Advisors
Idenix Pharmaceuticals, Inc.: Capital Raising
Idenix Pharmaceuticals, Inc.: Partnership
Idenix Pharmaceuticals, Inc.: Recent Developments
Idenix Pharmaceuticals, Inc.: News and Events Summary
Idenix Pharmaceuticals, Inc.: Corporate Governance
Idenix Pharmaceuticals, Inc.: Financial Performance
Idenix Pharmaceuticals, Inc.: Research & Development
Appendix
Contact Us
Methodology
Definitions


List of Tables

Table 1: Idenix Pharmaceuticals, Inc.: Key Facts
Table 2: Idenix Pharmaceuticals, Inc.: Key Employees
Table 4: Idenix Pharmaceuticals, Inc.: Key Competitors
Table 5: Idenix Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Idenix Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Table 7: Idenix Pharmaceuticals, Inc.: Targets and Partners
Table 8: Idenix Pharmaceuticals, Inc.: Top Deals 2009 - 2013YTD*
Table 9: Idenix Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (US$m)
Table 10: Idenix Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (US$m)
Table 11: Idenix Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2009 - YTD*2013)
Table 12: Idenix Pharmaceuticals, Inc.: Capital Raising by Deal Type (2009 - YTD*2013)
Table 13: Idenix Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2009 - YTD*2013)
Table 14: Idenix Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2009 - YTD*2013)
Table 15: Idenix Pharmaceuticals, Inc.: News and Events Summary
Table 16: Idenix Pharmaceuticals, Inc.: Corporate Governance
Table 17: Idenix Pharmaceuticals, Inc.: Financial Performance
Table 18: Idenix Pharmaceuticals, Inc.: Research & Development

List of Figures

Figure 1: Idenix Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Idenix Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Figure 3: Idenix Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2009 - YTD*2013)
Figure 4: Idenix Pharmaceuticals, Inc.: Capital Raising by Deal Type (2009 - YTD*2013)
Figure 5: Idenix Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2009 - YTD*2013)
Figure 6: Idenix Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2009 - YTD*2013)
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.